Insider Transactions in Q4 2024 at Bicycle Therapeutics PLC (BCYC)
Insider Transaction List (Q4 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 16
2024
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
500,000
+4.4%
|
$7,500,000
$15.34 P/Share
|
Dec 13
2024
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
985,397
+2.34%
|
$12,810,161
$13.66 P/Share
|
Nov 11
2024
|
Travis Alvin Thompson CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
6,256
-4.51%
|
$150,144
$24.99 P/Share
|
Nov 11
2024
|
Travis Alvin Thompson CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,575
+3.4%
|
$15,450
$6.63 P/Share
|
Oct 03
2024
|
Travis Alvin Thompson CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
153
-0.66%
|
$3,366
$22.26 P/Share
|
Oct 03
2024
|
Nigel Crockett CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
972
-2.08%
|
$21,384
$22.26 P/Share
|
Oct 03
2024
|
Alistair Milnes CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
972
-1.36%
|
$21,384
$22.26 P/Share
|
Oct 03
2024
|
Michael Skynner CHIEF TECHNOLOGY OFFICER |
SELL
Open market or private sale
|
Direct |
972
-1.04%
|
$21,384
$22.26 P/Share
|
Oct 03
2024
|
Michael Charles Ferguson Hannay CHIEF PROD & SUPPLY CHAIN OFF |
SELL
Open market or private sale
|
Direct |
247
-1.09%
|
$5,434
$22.26 P/Share
|
Oct 03
2024
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
3,212
-0.84%
|
$70,664
$22.26 P/Share
|